Loading…
Is Roux-en-Y gastric bypass adequate in the super-obese?
The outcome after Roux-en-Y gastric bypass (RYGBP) in morbidly obese (MO) (body mass index [BMI] 40-50) was compared with super-obese (SO) (BMI >50) and super-super-obese (SSO) (BMI >60) patients. A prospective study was conducted in 738 consecutive patients who underwent RYGBP. 483 MO were co...
Saved in:
Published in: | Obesity surgery 2006-04, Vol.16 (4), p.478-483 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c328t-9c5cfee8280b77ad56cdea7c1b506c883f984f3221ec7baf799b83262fb8224c3 |
---|---|
cites | |
container_end_page | 483 |
container_issue | 4 |
container_start_page | 478 |
container_title | Obesity surgery |
container_volume | 16 |
creator | Sánchez-Santos, Raquel Vilarrasa, Nuria Pujol, Jorge Moreno, Pablo Manuel Francos, Jose Rafecas, Antonio Masdevall, Carlos |
description | The outcome after Roux-en-Y gastric bypass (RYGBP) in morbidly obese (MO) (body mass index [BMI] 40-50) was compared with super-obese (SO) (BMI >50) and super-super-obese (SSO) (BMI >60) patients.
A prospective study was conducted in 738 consecutive patients who underwent RYGBP. 483 MO were compared with 184 SO and 70 SSO. Study endpoints included: effect on co-morbid conditions, postoperative morbidity and mortality, and long-term results. Statistical analysis utilized SPSS 11.0.
Percentage of males was significantly greater in the SO groups (16.5% vs 13%, P=0.01). Obesity-related conditions were significantly more frequent in the SO groups: sleep apnea (38% vs 17%, P50% at 5 years was: MO 81.5%, SO 87.5%, SSO 80%. The surgery was effective in treating the co-morbid conditions.
RYGBP achieved significant durable weight loss and effectively treated co-morbid conditions in SO and SSO patients with acceptable postoperative morbidity and slightly greater mortality than in MO patients. |
doi_str_mv | 10.1381/096089206776327224 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67861415</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67861415</sourcerecordid><originalsourceid>FETCH-LOGICAL-c328t-9c5cfee8280b77ad56cdea7c1b506c883f984f3221ec7baf799b83262fb8224c3</originalsourceid><addsrcrecordid>eNplkM9LwzAYhoMobk7_AQ9SPHiLJl_aJD2JDH8MBoLowVNJ0q_asbVd0sD239uxgaCn7_K8L9_7EHLJ2S0Xmt-xXDKdA5NKSQEKID0iY66YpiwFfUzGO4AOhBiRsxAWjAGXAKdkxOWQlDwdEz0LyVsbNxQb-pl8mdD72iV225kQElPiOpoek7pJ-m9MQuzQ09ZiwPtzclKZZcCLw52Qj6fH9-kLnb8-z6YPc-oE6J7mLnMVogbNrFKmzKQr0SjHbcak01pUuU4rAcDRKWsqledWC5BQWT0McmJCbva9nW_XEUNfrOrgcLk0DbYxFFLthvBsAK__gIs2-mb4rdDAOcskhwGCPeR8G4LHquh8vTJ-W3BW7KQW_6UOoatDc7QrLH8jB4viB0Mxb6E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>821105612</pqid></control><display><type>article</type><title>Is Roux-en-Y gastric bypass adequate in the super-obese?</title><source>Springer Nature</source><creator>Sánchez-Santos, Raquel ; Vilarrasa, Nuria ; Pujol, Jorge ; Moreno, Pablo ; Manuel Francos, Jose ; Rafecas, Antonio ; Masdevall, Carlos</creator><creatorcontrib>Sánchez-Santos, Raquel ; Vilarrasa, Nuria ; Pujol, Jorge ; Moreno, Pablo ; Manuel Francos, Jose ; Rafecas, Antonio ; Masdevall, Carlos</creatorcontrib><description>The outcome after Roux-en-Y gastric bypass (RYGBP) in morbidly obese (MO) (body mass index [BMI] 40-50) was compared with super-obese (SO) (BMI >50) and super-super-obese (SSO) (BMI >60) patients.
A prospective study was conducted in 738 consecutive patients who underwent RYGBP. 483 MO were compared with 184 SO and 70 SSO. Study endpoints included: effect on co-morbid conditions, postoperative morbidity and mortality, and long-term results. Statistical analysis utilized SPSS 11.0.
Percentage of males was significantly greater in the SO groups (16.5% vs 13%, P=0.01). Obesity-related conditions were significantly more frequent in the SO groups: sleep apnea (38% vs 17%, P<0.0005), gallstones (23% vs 14%, P=0.013); diabetes (29% vs 17%, P=0.002). Hospital stay was longer in the SO groups (5.7+/-6.1 days vs 4.6+/-2.6 days, P=0.024). Wound infection was more frequent in the SO groups (4.7% vs 1.4%, P=0.019). Postoperative mortality was greater in the SSO and SO groups (1.6% and 1.4%) than MO (0%) (P=0.019). Incisional hernia was more frequent in the SO groups (14.1% vs 8.6%; P=0.041). There was no significant difference in percent of excess weight loss (%EWL) between the three groups. EWL >50% at 5 years was: MO 81.5%, SO 87.5%, SSO 80%. The surgery was effective in treating the co-morbid conditions.
RYGBP achieved significant durable weight loss and effectively treated co-morbid conditions in SO and SSO patients with acceptable postoperative morbidity and slightly greater mortality than in MO patients.</description><identifier>ISSN: 0960-8923</identifier><identifier>EISSN: 1708-0428</identifier><identifier>DOI: 10.1381/096089206776327224</identifier><identifier>PMID: 16608614</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Body Mass Index ; Body Weight ; Comorbidity ; Diabetes Mellitus - epidemiology ; Female ; Gallstones - epidemiology ; Gastric Bypass - adverse effects ; Gastric Bypass - methods ; Gastric Bypass - mortality ; Humans ; Laparoscopy ; Length of Stay ; Male ; Medical treatment ; Middle Aged ; Mortality ; Obesity, Morbid - epidemiology ; Obesity, Morbid - surgery ; Postoperative Complications - epidemiology ; Prospective Studies ; Sleep Apnea Syndromes - epidemiology ; Surgery ; Treatment Outcome ; Weight Loss</subject><ispartof>Obesity surgery, 2006-04, Vol.16 (4), p.478-483</ispartof><rights>Springer 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c328t-9c5cfee8280b77ad56cdea7c1b506c883f984f3221ec7baf799b83262fb8224c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16608614$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sánchez-Santos, Raquel</creatorcontrib><creatorcontrib>Vilarrasa, Nuria</creatorcontrib><creatorcontrib>Pujol, Jorge</creatorcontrib><creatorcontrib>Moreno, Pablo</creatorcontrib><creatorcontrib>Manuel Francos, Jose</creatorcontrib><creatorcontrib>Rafecas, Antonio</creatorcontrib><creatorcontrib>Masdevall, Carlos</creatorcontrib><title>Is Roux-en-Y gastric bypass adequate in the super-obese?</title><title>Obesity surgery</title><addtitle>Obes Surg</addtitle><description>The outcome after Roux-en-Y gastric bypass (RYGBP) in morbidly obese (MO) (body mass index [BMI] 40-50) was compared with super-obese (SO) (BMI >50) and super-super-obese (SSO) (BMI >60) patients.
A prospective study was conducted in 738 consecutive patients who underwent RYGBP. 483 MO were compared with 184 SO and 70 SSO. Study endpoints included: effect on co-morbid conditions, postoperative morbidity and mortality, and long-term results. Statistical analysis utilized SPSS 11.0.
Percentage of males was significantly greater in the SO groups (16.5% vs 13%, P=0.01). Obesity-related conditions were significantly more frequent in the SO groups: sleep apnea (38% vs 17%, P<0.0005), gallstones (23% vs 14%, P=0.013); diabetes (29% vs 17%, P=0.002). Hospital stay was longer in the SO groups (5.7+/-6.1 days vs 4.6+/-2.6 days, P=0.024). Wound infection was more frequent in the SO groups (4.7% vs 1.4%, P=0.019). Postoperative mortality was greater in the SSO and SO groups (1.6% and 1.4%) than MO (0%) (P=0.019). Incisional hernia was more frequent in the SO groups (14.1% vs 8.6%; P=0.041). There was no significant difference in percent of excess weight loss (%EWL) between the three groups. EWL >50% at 5 years was: MO 81.5%, SO 87.5%, SSO 80%. The surgery was effective in treating the co-morbid conditions.
RYGBP achieved significant durable weight loss and effectively treated co-morbid conditions in SO and SSO patients with acceptable postoperative morbidity and slightly greater mortality than in MO patients.</description><subject>Body Mass Index</subject><subject>Body Weight</subject><subject>Comorbidity</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Female</subject><subject>Gallstones - epidemiology</subject><subject>Gastric Bypass - adverse effects</subject><subject>Gastric Bypass - methods</subject><subject>Gastric Bypass - mortality</subject><subject>Humans</subject><subject>Laparoscopy</subject><subject>Length of Stay</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Obesity, Morbid - epidemiology</subject><subject>Obesity, Morbid - surgery</subject><subject>Postoperative Complications - epidemiology</subject><subject>Prospective Studies</subject><subject>Sleep Apnea Syndromes - epidemiology</subject><subject>Surgery</subject><subject>Treatment Outcome</subject><subject>Weight Loss</subject><issn>0960-8923</issn><issn>1708-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNplkM9LwzAYhoMobk7_AQ9SPHiLJl_aJD2JDH8MBoLowVNJ0q_asbVd0sD239uxgaCn7_K8L9_7EHLJ2S0Xmt-xXDKdA5NKSQEKID0iY66YpiwFfUzGO4AOhBiRsxAWjAGXAKdkxOWQlDwdEz0LyVsbNxQb-pl8mdD72iV225kQElPiOpoek7pJ-m9MQuzQ09ZiwPtzclKZZcCLw52Qj6fH9-kLnb8-z6YPc-oE6J7mLnMVogbNrFKmzKQr0SjHbcak01pUuU4rAcDRKWsqledWC5BQWT0McmJCbva9nW_XEUNfrOrgcLk0DbYxFFLthvBsAK__gIs2-mb4rdDAOcskhwGCPeR8G4LHquh8vTJ-W3BW7KQW_6UOoatDc7QrLH8jB4viB0Mxb6E</recordid><startdate>200604</startdate><enddate>200604</enddate><creator>Sánchez-Santos, Raquel</creator><creator>Vilarrasa, Nuria</creator><creator>Pujol, Jorge</creator><creator>Moreno, Pablo</creator><creator>Manuel Francos, Jose</creator><creator>Rafecas, Antonio</creator><creator>Masdevall, Carlos</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>200604</creationdate><title>Is Roux-en-Y gastric bypass adequate in the super-obese?</title><author>Sánchez-Santos, Raquel ; Vilarrasa, Nuria ; Pujol, Jorge ; Moreno, Pablo ; Manuel Francos, Jose ; Rafecas, Antonio ; Masdevall, Carlos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c328t-9c5cfee8280b77ad56cdea7c1b506c883f984f3221ec7baf799b83262fb8224c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Body Mass Index</topic><topic>Body Weight</topic><topic>Comorbidity</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Female</topic><topic>Gallstones - epidemiology</topic><topic>Gastric Bypass - adverse effects</topic><topic>Gastric Bypass - methods</topic><topic>Gastric Bypass - mortality</topic><topic>Humans</topic><topic>Laparoscopy</topic><topic>Length of Stay</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Obesity, Morbid - epidemiology</topic><topic>Obesity, Morbid - surgery</topic><topic>Postoperative Complications - epidemiology</topic><topic>Prospective Studies</topic><topic>Sleep Apnea Syndromes - epidemiology</topic><topic>Surgery</topic><topic>Treatment Outcome</topic><topic>Weight Loss</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sánchez-Santos, Raquel</creatorcontrib><creatorcontrib>Vilarrasa, Nuria</creatorcontrib><creatorcontrib>Pujol, Jorge</creatorcontrib><creatorcontrib>Moreno, Pablo</creatorcontrib><creatorcontrib>Manuel Francos, Jose</creatorcontrib><creatorcontrib>Rafecas, Antonio</creatorcontrib><creatorcontrib>Masdevall, Carlos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Obesity surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sánchez-Santos, Raquel</au><au>Vilarrasa, Nuria</au><au>Pujol, Jorge</au><au>Moreno, Pablo</au><au>Manuel Francos, Jose</au><au>Rafecas, Antonio</au><au>Masdevall, Carlos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is Roux-en-Y gastric bypass adequate in the super-obese?</atitle><jtitle>Obesity surgery</jtitle><addtitle>Obes Surg</addtitle><date>2006-04</date><risdate>2006</risdate><volume>16</volume><issue>4</issue><spage>478</spage><epage>483</epage><pages>478-483</pages><issn>0960-8923</issn><eissn>1708-0428</eissn><abstract>The outcome after Roux-en-Y gastric bypass (RYGBP) in morbidly obese (MO) (body mass index [BMI] 40-50) was compared with super-obese (SO) (BMI >50) and super-super-obese (SSO) (BMI >60) patients.
A prospective study was conducted in 738 consecutive patients who underwent RYGBP. 483 MO were compared with 184 SO and 70 SSO. Study endpoints included: effect on co-morbid conditions, postoperative morbidity and mortality, and long-term results. Statistical analysis utilized SPSS 11.0.
Percentage of males was significantly greater in the SO groups (16.5% vs 13%, P=0.01). Obesity-related conditions were significantly more frequent in the SO groups: sleep apnea (38% vs 17%, P<0.0005), gallstones (23% vs 14%, P=0.013); diabetes (29% vs 17%, P=0.002). Hospital stay was longer in the SO groups (5.7+/-6.1 days vs 4.6+/-2.6 days, P=0.024). Wound infection was more frequent in the SO groups (4.7% vs 1.4%, P=0.019). Postoperative mortality was greater in the SSO and SO groups (1.6% and 1.4%) than MO (0%) (P=0.019). Incisional hernia was more frequent in the SO groups (14.1% vs 8.6%; P=0.041). There was no significant difference in percent of excess weight loss (%EWL) between the three groups. EWL >50% at 5 years was: MO 81.5%, SO 87.5%, SSO 80%. The surgery was effective in treating the co-morbid conditions.
RYGBP achieved significant durable weight loss and effectively treated co-morbid conditions in SO and SSO patients with acceptable postoperative morbidity and slightly greater mortality than in MO patients.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>16608614</pmid><doi>10.1381/096089206776327224</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-8923 |
ispartof | Obesity surgery, 2006-04, Vol.16 (4), p.478-483 |
issn | 0960-8923 1708-0428 |
language | eng |
recordid | cdi_proquest_miscellaneous_67861415 |
source | Springer Nature |
subjects | Body Mass Index Body Weight Comorbidity Diabetes Mellitus - epidemiology Female Gallstones - epidemiology Gastric Bypass - adverse effects Gastric Bypass - methods Gastric Bypass - mortality Humans Laparoscopy Length of Stay Male Medical treatment Middle Aged Mortality Obesity, Morbid - epidemiology Obesity, Morbid - surgery Postoperative Complications - epidemiology Prospective Studies Sleep Apnea Syndromes - epidemiology Surgery Treatment Outcome Weight Loss |
title | Is Roux-en-Y gastric bypass adequate in the super-obese? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A30%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20Roux-en-Y%20gastric%20bypass%20adequate%20in%20the%20super-obese?&rft.jtitle=Obesity%20surgery&rft.au=S%C3%A1nchez-Santos,%20Raquel&rft.date=2006-04&rft.volume=16&rft.issue=4&rft.spage=478&rft.epage=483&rft.pages=478-483&rft.issn=0960-8923&rft.eissn=1708-0428&rft_id=info:doi/10.1381/096089206776327224&rft_dat=%3Cproquest_cross%3E67861415%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c328t-9c5cfee8280b77ad56cdea7c1b506c883f984f3221ec7baf799b83262fb8224c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=821105612&rft_id=info:pmid/16608614&rfr_iscdi=true |